C Randal Mills Aziyo Biologics, Inc. (AZYO) insider trading activity

C Randal Mills is PRESIDENT AND CEO of AZIYO BIOLOGICS, INC.. Currently has a direct ownership of 338,586 shares of AZYO, which is worth approximately $490,949. The most recent transaction as insider was on Sep 10, 2025, when has been sold 9,664 shares (Class A Common Stock) at a price of $1.36 per share, resulting in proceeds of $13,143. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 339K

5.42% 3M change

33.33% 12M change

Total Value Held $490,949

C Randal Mills Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 10 2025	SELL Payment of exercise price or tax liability	$13,143 $1.36 p/Share	9,664 Reduced 2.78%	338,586 Class A Common Stock
Sep 10 2025	BUY Exercise of conversion of derivative security	-	27,083 Added 7.22%	348,250 Class A Common Stock
Jun 21 2025	SELL Payment of exercise price or tax liability	$14,514 $1.81 p/Share	8,019 Reduced 2.44%	321,167 Class A Common Stock
Jun 21 2025	BUY Exercise of conversion of derivative security	-	22,473 Added 6.39%	329,186 Class A Common Stock
Jun 10 2025	SELL Payment of exercise price or tax liability	$19,231 $1.99 p/Share	9,664 Reduced 3.05%	306,713 Class A Common Stock
Jun 10 2025	BUY Exercise of conversion of derivative security	-	27,084 Added 7.89%	316,377 Class A Common Stock
Mar 10 2025	SELL Payment of exercise price or tax liability	$32,118 $3.0 p/Share	10,706 Reduced 3.57%	289,293 Class A Common Stock
Mar 10 2025	BUY Exercise of conversion of derivative security	-	27,083 Added 8.28%	299,999 Class A Common Stock
Dec 10 2024	SELL Payment of exercise price or tax liability	$58,884 $4.29 p/Share	13,726 Reduced 4.88%	267,298 Class A Common Stock
Dec 10 2024	BUY Exercise of conversion of derivative security	-	27,083 Added 8.79%	281,024 Class A Common Stock
Sep 10 2024	SELL Payment of exercise price or tax liability	$40,008 $4.14 p/Share	9,664 Reduced 3.67%	253,941 Class A Common Stock
Sep 10 2024	BUY Exercise of conversion of derivative security	-	27,084 Added 9.32%	263,605 Class A Common Stock
Aug 12 2024	SELL Payment of exercise price or tax liability	$166,591 $2.84 p/Share	58,659 Reduced 20.06%	233,808 Class A Common Stock
Aug 12 2024	BUY Exercise of conversion of derivative security	-	162,500 Added 35.72%	292,467 Class A Common Stock
Jun 21 2024	SELL Payment of exercise price or tax liability	$28,066 $3.5 p/Share	8,019 Reduced 5.81%	129,967 Class A Common Stock
Jun 21 2024	BUY Exercise of conversion of derivative security	-	22,473 Added 14.01%	137,986 Class A Common Stock
Jun 10 2024	SELL Payment of exercise price or tax liability	$67,064 $3.47 p/Share	19,327 Reduced 14.33%	115,513 Class A Common Stock
Jun 10 2024	BUY Exercise of conversion of derivative security	-	54,167 Added 28.66%	134,840 Class A Common Stock
Jun 21 2023	SELL Payment of exercise price or tax liability	$18,730 $2.41 p/Share	7,772 Reduced 11.03%	62,710 Class A Common Stock
Jun 21 2023	BUY Exercise of conversion of derivative security	-	22,474 Added 24.18%	70,482 Class A Common Stock
Apr 27 2023	BUY Exercise of conversion of derivative security	-	44,947 Added 48.35%	48,008 Class A Common Stock

CRM

C Randal Mills

PRESIDENT AND CEO

Silver Spring, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AZYO shares.

Notify only if

Value

Insider Trading

Get notified when an Aziyo Biologics, Inc. insider buys or sells AZYO shares.

Notify only if

Operation

Value

Type

News

Receive news related to AZIYO BIOLOGICS, INC.

Track Activities on AZYO

Account